explore -WSS

explore

author：comprehensive 2025-10-01 14:16:02 - browse：9

People in business and medical wardrobe in a table discussion — coverage from STAT — Adobe

R1 RCM, a large publicly traded technology company that helps hospitals and physicians collect money from insurers and patients, may be going private.

Private equity firm New Mountain Capital has offered to purchase R1 for $13.75 per share, or roughly $5.8 billion in cash, according to new financial disclosures filed Monday. New Mountain Capital is R1’s second-largest investor, owning nearly one-third of the company’s shares.

In response to the offer, R1 asked New Mountain Capital to “engage in good faith discussions” with its largest investor — a partnership between Ascension, the large Catholic hospital system, and private equity firm TowerBrook Capital Partners. New Mountain Capital has since held several in-person meetings with Ascension and TowerBrook throughout February, but maintained its original offer for R1. No deal has been finalized yet.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： GOP inquiry over gain

Wikipedia

WSS

Supreme Court rules employers must be more accommodating of religious observance

The sun may be out, but guns are not. A lawsuit challenges a new gun ban on Hawaii beaches

Why do we get seasonal allergies?

Medicare’s new pay boost for primary care is angering specialists

Synthetic human embryos? Researchers say term is overblown

Federal board approves $12.7 billion budget for Puerto Rico as island shakes off bankruptcy

Wikipedia

explore

entertainment

Dobbs anniversary: the lost opportunity of abortion as health care

Readout LOUD Podcast: Lilly's obesity drug, the power of radiation

Jerome Adams on the need for new antivirals for Covid

Newly formed Hurricane Beatriz sweeps close to Mexico's southwest Pacific coast

Alkermes shareholders re

Readout Newsletter: Ozempic panic wanes, Legend x Novartis, etc.

After affirmative action ruling, medical educators look to 'holistic review'

Readout Newsletter: Ozempic panic wanes, Legend x Novartis, etc.

The cancer drug shortage isn’t new — and neither are the solutions

Here's how to stay safe from wildfire smoke amid reduced air quality

leisure time

ADA: All diabetes patients should be screened for liver condition

Belarusian journalist sentenced to 4 years in prison as crackdown continues

White House drug czar issues call for 'recovery

Biden slams SCOTUS affirmative action decision: 'Discrimination still exists in America'

FDA cancer chief on how to get things done: ‘Don’t tell anybody'

Ventyx halts psoriasis drug development after lackluster trial results

knowledge

Wikipedia

hotspot

explore